VGX-410 (Mifepristone)

DRUG2 trials

Sponsors

VGX Pharmaceuticals, LLC

Conditions

HIV InfectionsHepatitis C Virus Infection

Phase 2

Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients

CompletedNCT00255177

VGX Pharmaceuticals, LLCHepatitis C Virus Infection

Start: 2005-11-30End: 2008-01-31Updated: 2009-11-03

Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects

CompletedNCT00352911

VGX Pharmaceuticals, LLCHIV Infections

Start: 2006-07-31End: 2007-11-30Updated: 2010-03-09